{"id":"doi:10.1038/s41591-018-0050-6","kind":"article","title":"p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells","authors":["Robert J. Ihry","Kathleen A. Worringer","Max R. Salick","Elizabeth Frias","Daniel J. Ho","Kraig M. Theriault","Sravya Kommineni","Julie Chen","Marie Sondey","Chaoyang Ye","Ranjit Randhawa","Tripti Kulkarni","Zinger Yang","Gregory McAllister","Carsten Russ","John S. Reece-Hoyes","William C. Forrester","Gregory R. Hoffman","Ricardo E. Dolmetsch","Ajamete Kaykas"],"author_count":20,"year":2018,"published":"2018-06-08","venue":"Nature Medicine","cited_by":977,"doi":"10.1038/s41591-018-0050-6","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1038/s41591-018-0050-6","archive_url":"https://space-kitty.com/papers/doi:10.1038/s41591-018-0050-6","updated":null,"pmid":"29892062","pmcid":null,"openalex_id":"W2807198924","pdf_url":"https://www.biorxiv.org/content/biorxiv/early/2017/07/26/168443.full.pdf","abstract":null,"abstract_license":null,"license":"cc-by-nc-nd","is_open_access":true,"retracted":false,"peer_reviewed":null,"categories":["CRISPR and Genetic Engineering"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"gene-editing-therapies","name":"CRISPR & Gene-Editing Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[]}